Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din, Mona Mansour Salem, Dina Ossama Abdulazim

Effect of SGLT2 inhibitors on anemia and their possible clinical implications Aleix Cases, Secundino Cigarrán, José Luis Górriz, Julio Nuñez

Risk of mortality associated to chronic kidney disease in patients with type 2 diabetes mellitus: A 13-year follow-up José Antonio Gimeno-Orna, Yolanda Blasco-Lamarca, Belén Campos-Gutierrez, Edmundo Molinero-Herguedas, Luis Miguel Lou-Arnal, Blanca García-García